Compare BioNano Genomics Inc (BNGO) vs Deutsche Bank AG (DB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Deutsche Bank AG — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Deutsche Bank AG trades at $38.21 (market cap $71.96B). The key difference: Deutsche Bank AG is far larger — about 5267.9× BioNano Genomics Inc's market cap, and Deutsche Bank AG pays a 3.04% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | DB | |
|---|---|---|
Market Cap | $13.66M | $71.96B |
Sector | Health | Financials |
52-Week High | $4.92 | $40.33 |
52-Week Low | $1.06 | $28.37 |
Enterprise Value | $16.26M | — |
Dividend Yield | — | 3.04% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →
